Hanna Mäenpää

6.4k citations
54 papers · 4.8k indexed · 2 hit papers · h-index 22
Topics
Thyroid Cancer Diagnosis and Treatment (9 papers)Retinal Development and Disorders (7 papers)Glioma Diagnosis and Treatment (6 papers)

In The Last Decade

Hanna Mäenpää

51 papers receiving 4.5k citations

Hit Papers

Helsinki Heart Study: Primary-Prevention Trial with Gemfi...19872026200020131987199850010001.5k2.0k2.5k

Peers

Hanna Mäenpää
Comparison fields: 5 of 132
  • Surgery 2.0k
  • Endocrinology, Diabetes and Metabolism 1.7k
  • Molecular Biology 945
  • Cancer Research 825
  • Cardiology and Cardiovascular Medicine 746
Replace Dennis L. Sprecher with:
Dennis L. Sprecher United States
Alexandros D. Tselepis Greece
Joseph P. McConnell United States
Rafael Carmena Spain
Benjamin J. Ansell United States
P. Barton Duell United States
Tamio Teramoto Japan
Leiv Ose Norway
Heinrich Wieland Germany
Hubert Scharnagl Austria
Hanna Mäenpää relative to Dennis L. Sprecher United States Dennis L. Sprecher's profile →
Citations per field
00.5×1.5×
Dennis L. Sprecher · 1×
Citations per year

Countries citing papers authored by Hanna Mäenpää

Since Specialization
Citations

This map shows the geographic impact of Hanna Mäenpää's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanna Mäenpää with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanna Mäenpää more than expected).

Fields of papers citing papers by Hanna Mäenpää

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanna Mäenpää. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanna Mäenpää. The network helps show where Hanna Mäenpää may publish in the future.

Co-authorship network of co-authors of Hanna Mäenpää

This figure shows the co-authorship network connecting the top 25 collaborators of Hanna Mäenpää. A scholar is included among the top collaborators of Hanna Mäenpää based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanna Mäenpää. Hanna Mäenpää is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 38
3 21
4 9
5 3
6 20
7 27
8 81
9 8
10 5
11 29
12 35
13 33
14 103
15
Prostate Cancer and Supplementation With α-Tocopherol and β-Carotene: Incidence and Mortality in a Controlled Trialbreakdown →
665
16 3
17 0
18 88
19 6
20
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemiabreakdown →
2943

About Hanna Mäenpää

Hanna Mäenpää is a scholar working on Ophthalmology, Cancer Research and Endocrinology, Diabetes and Metabolism, having authored 54 papers that have together received 4.8k indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (9 papers), Retinal Development and Disorders (7 papers) and Glioma Diagnosis and Treatment (6 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.7k citations), Biochemistry (400 citations) and Cancer Research (825 citations). Hanna Mäenpää has collaborated with scholars based in Finland, United States and Malaysia. Frequent co-authors include Jussi K. Huttunen, Olli P. Heinonen, Vesa Manninen, Matti Mänttäri, M. H. Frick, Pekka Koskinen, Amos Pasternack, Esko A. Nikkilä, Matti Romo and J Pikkarainen. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026